Good afternoon :)
Switch to
Add to Watchlist

Earum Pharmaceuticals Ltd

EARUM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹153 cr, stock is ranked 1,701
High RiskStock is 3.10x as volatile as Nifty
126.501.75 (+1.40%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹153 cr, stock is ranked 1,701
High RiskStock is 3.10x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
1,709.88
PB RatioPB Ratio
10.61
Dividend YieldDiv. Yield
Sector PESector PE
40.04
Sector PBSector PB
5.36
Sector Div YldSctr Div Yld
0.64%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Earum Pharmaceuticals is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, anti-malarial drugs, anti-allergic & anti cold drugs etc

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

201820192020202135.8550.7557.3850.010.911.651.810.09
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Company Update 
Announced OnSep 15, 2021

Earum Pharmaceuticals Ltd - 542724 - Confirmation Letter Regarding No Other Material Reason In Case Of Resignation Of An Independent Director | Download

Earum Pharmaceuticals Ltd - 542724 - Confirmation Letter Regarding No Other Material Reason In Case Of Resignation Of An Independent Director | Download

Company Update 
Announced OnSep 7, 2021

Earum Pharmaceuticals Ltd - 542724 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Mr. Bhavesh N. Sonesara And Mr. Harsh M. Kothari As An Additional Director In The Category Of Independent Director | Download

Earum Pharmaceuticals Ltd - 542724 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Appointment Of Mr. Bhavesh N. Sonesara And Mr. Harsh M. Kothari As An Additional Director In The Category Of Independent Director | Download

Company Update 
Announced OnSep 7, 2021

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Director | Download

Earum Pharmaceuticals Ltd - 542724 - Announcement under Regulation 30 (LODR)-Resignation of Director | Download

See all events